Showing results (321-330 of 412) with videos related to

Sort By:
Pageof 42
Clinical Endocrinology|November 1, 1995
Treatment of post-menopausal osteoporosis with a combination of growth hormone and pamidronate: a placebo controlled trialR J Erdtsieck, H A Pols, N K Valk, et al.
European Journal of Clinical Investigation|February 1, 1994
Somatostatin and the immune and haematopoetic system; a reviewP M van Hagen, E P Krenning, D J Kwekkeboom, et al.
Human Reproduction (Oxford, England)|June 1, 1994
Pre-clinical and clinical treatment of breast cancer with antiprogestinsJ G Klijn, B Setyono-Han, H J Sander, et al.
World Journal of Surgery|July 1, 1993
Use of isotope-labeled somatostatin analogs for visualization of islet cell tumorsC H van Eyck, H A Bruining, J C Reubi, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1993
Glomerular hyperfiltration in insulin-dependent diabetes mellitus is correlated with enhanced growth hormone secretionP J Blankestijn, F H Derkx, J C Birkenhäger, et al.
The Journal of Clinical Endocrinology and Metabolism|February 7, 2001
Control of tumor size and disease activity during cotreatment with octreotide and the growth hormone receptor antagonist pegvisomant in an acromegalic patientA J van der Lely, A Muller, J A Janssen, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1986
High incidence of somatostatin receptors in human meningiomas: biochemical characterizationJ C Reubi, R Maurer, J G Klijn, et al.
The Journal of Clinical Endocrinology and Metabolism|September 1, 1990
Parallel in vivo and in vitro detection of functional somatostatin receptors in human endocrine pancreatic tumors: consequences with regard to diagnosis, localization, and therapyS W Lamberts, L J Hofland, P M van Koetsveld, et al.
Endocrinology|August 1, 1989
Hypothyroidism may account for reduced prolactin secretion in lactating rats bearing paraventricular area lesionsW J de Greef, J M Rondeel, P D van der Vaart, et al.
The Journal of Clinical Endocrinology and Metabolism|February 7, 2001
Blockade of the growth hormone (GH) receptor unmasks rapid GH-releasing peptide-6-mediated tissue-specific insulin resistanceA F Muller, J A Janssen, L J Hofland, et al.
Pageof 42